Skip to main content

Clinical Management of Ebola Virus Disease Patients in Low-Resource Settings

  • Chapter
  • First Online:
Marburg- and Ebolaviruses

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 411))

Abstract

The low-resource environment deprives healthcare providers caring for patients with Ebola virus disease (EVD) of many of the means employed for the critically ill that are available in better resourced settings, such as advanced therapeutic interventions and abundant staff. In addition to these limitations may be added those imposed by the remote tropical locations, where EVD outbreaks occur. In this setting, a safe environment is created where healthcare workers may care for their patients over the evolving course of their acute illness into their convalescent period. Clinical management of EVD combines supportive and symptomatic care while also addressing the patient’s emotional and mental health needs. A variety of specific therapies directly targeting the virus has become available, but none of these has, as of yet, conclusively demonstrated an impact. Healthcare workers caring for EVD patients must be constantly aware that they are part of a larger epidemic control operation, and their actions have consequences that go beyond their patients to their families and the community affected by the outbreak.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Bray M, Chertow D (2016) Filoviruses. In: Richman D, Whitley R, Hayden F (eds) Clinical virology, 4th edn. ASM Press, Washington, DC, pp 1–28

    Google Scholar 

  • Caluwaerts S, Fautsch T, Lagrou D (2016) Dilemmas in managing pregnant women with Ebola: 2 case reports. Clin Infect Dis 62(7):903–905

    Article  PubMed  Google Scholar 

  • Davey RT, The Multi-National PREVAIL II Study Team (2016) PREVAIL II: A randomized controlled trial of ZMapp™ in Acute Ebola virus infection. Presented at the conference on retroviruses and opportunistic infections, Boston, 22–25 Feb 2016

    Google Scholar 

  • Dellinger RP, Levy MM, Rhodes A (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41(2):580–637

    Article  PubMed  Google Scholar 

  • Dörnemann J, Burzio C, Ronsse A et al (2017) First newborn baby to receive experimental therapies survives Ebola virus disease. J infect Dis 215(2):171–174

    Google Scholar 

  • Dunning J, Sahr F, Rojek A et al (2016) Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial. PLoS Med 13(4):e1001997

    Article  PubMed  PubMed Central  Google Scholar 

  • Emond RT, Evans B, Bowen ET et al (1977) A case of Ebola virus infection. Br Med J 2:541–544

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Evlampidou I, Rabelo I, Lee V (2016) Psychological suffering among Ebola virus disease survivors in Monrovia, Liberia: a mixed methods study. Front Public Health 4:142

    PubMed  PubMed Central  Google Scholar 

  • Henao-Restrepo AM, Longini IM, Egger M et al (2015) Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet 386(9996):857–866

    Article  CAS  PubMed  Google Scholar 

  • Howlett P, Brown C, Helderman T (2016) Ebola virus disease complicated by late-onset encephalitis and polyarthritis, Sierra Leone. Emerg Infect Dis 22(1):150–152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • International Food Policy Research Institute (IFPRI) (2016) Global nutrition report 2016: from promise to impact: ending malnutrition by 2030. Washington, DC

    Google Scholar 

  • Jacobs M, Rodger A, Bell DJ (2016) Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet 388(10043):498–503

    Article  PubMed  PubMed Central  Google Scholar 

  • Kortepeter MG, Bausch DG, Bray M (2011) Basic clinical and laboratory features of filoviral hemorrhagic fever. J Infect Dis 204(Suppl 3):S810–S816

    Article  PubMed  Google Scholar 

  • Kreuels B, Wichmann D, Emmerich P et al (2014) A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 371(25):2394–2401

    Article  CAS  PubMed  Google Scholar 

  • Maganga GD, Kapetshi J, Berthet N et al (2014) Ebola virus disease in the Democratic Republic of Congo. N Engl J Med 371(22):2083–2091

    Article  CAS  PubMed  Google Scholar 

  • Mahanty S, Bray M (2004) Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4(8):487–498

    Article  CAS  PubMed  Google Scholar 

  • Maitland K, Kiguli S, Opoka RO et al (2011) Mortality after fluid bolus in African Children with severe infection. N Engl J Med 364(26):2483–2495

    Article  CAS  PubMed  Google Scholar 

  • Marais F, Minkler M, Gibson N (2016) A community-engaged infection prevention and control approach to Ebola. Health Promot Int 31(2):440–449

    Article  PubMed  Google Scholar 

  • Marik P, Bellomo R (2016) A rational approach to fluid therapy in sepsis. Br J Anaesth 116(3):339–349

    Article  CAS  PubMed  Google Scholar 

  • Martini GA, Schmidt HA (1968) Spermatogenic transmission of the “Marburg virus”: causes of “Marburg simian disease”. Klin Wochenschr 46:398–400 (In German)

    Article  CAS  PubMed  Google Scholar 

  • Mate SE, Kugelman JR, Nyenswah TG et al (2015) Molecular evidence of sexual transmission of Ebola virus. N Engl J Med 373(25):2448–2454

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • McElroy A (2015) Understanding bleeding in Ebola virus disease. Clin Adv Hematol Oncol 13(1):29–31

    PubMed  PubMed Central  Google Scholar 

  • Mupapa K, Mukundu W, Bwaka MA et al (1999a) Ebola hemorrhagic fever and pregnancy. J Infect Dis 179(Suppl 1):S11–S12

    Article  PubMed  Google Scholar 

  • Mupapa K, Massamba M, Kibadi K et al (1999b) Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis 179(Suppl 1):S18–S23

    Article  PubMed  Google Scholar 

  • The National Institute for Occupational Safety and Health (NIOSH) (2015) Hierarchy of controls. https://www.cdc.gov/niosh/topics/hierarchy/. Accessed 10 Aug 2016

  • Rabelo I, Lee V, Fallah MP et al (2016) Psychological distress among Ebola survivors discharged from an Ebola treatment unit in Monrovia, Liberia—a qualitative study. Front Public Health 4(142)

    Google Scholar 

  • Rollin PE, Bausch DG, Sanchez A (2007) Blood chemistry measurements and D-Dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola virus. J Infect Dis 196(Suppl 2):S364–S371

    Article  CAS  PubMed  Google Scholar 

  • Sissoko D, Laouenan C, Folkesson E et al. (2016) Experimental treatment with Favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med 13(3). doi:10.1371/journal.pmed.1001967

  • Spengler JR, McElroy AK, Harmon JR et al (2015) Relationship between Ebola virus real-time quantitative polymerase chain reaction-based threshold cycle value and virus isolation from human plasma. J Infect Dis 212(Suppl 2):S98–S100

    Article  Google Scholar 

  • Sprecher AG, Caluwaerts A, Draper M et al (2015) Personal protective equipment for filovirus epidemics: a call for better evidence. J Infect Dis 212(Suppl 2):S346–S349

    Article  Google Scholar 

  • United Nations, Department of Economic and Social Affairs, Population Division (2015) World population prospects: the 2015 revision. https://esa.un.org/unpd/wpp/. Accessed 10 Aug 2016

  • van Griensven J, Edwards T, de Lamballerie X et al (2016) Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med 374(1):33–42

    Article  PubMed  Google Scholar 

  • Vetter P, Kaiser L, Schibler M et al (2016) Sequelae of Ebola virus disease: the emergency within the emergency. Lancet Infect Dis 16(6):e82–e91

    Article  PubMed  Google Scholar 

  • Wamala JF, Lukwago L, Malimbo M et al (2010) Ebola hemorrhagic fever associated with novel virus strain Uganda 2007-2008. Emerg Infect Dis 16(7):1087–1092

    Article  PubMed  PubMed Central  Google Scholar 

  • WHO/UNICEF/WFP (2014) Interim guideline: nutritional care of children and adults with Ebola virus disease in treatment centres. Geneva, Switzerland

    Google Scholar 

  • Wong KK, Perdue CL, Malia J et al (2015) Monrovia medical unit. Supportive care of the first 2 Ebola virus disease patients at the Monrovia medical unit. Clin Infect Dis 61(7):e47–e51

    Article  PubMed  Google Scholar 

  • World Health Organization (2014) Case definition recommendations for Ebola or Marburg virus diseases. http://www.who.int/csr/resources/publications/ebola/case-definition/en/. Accessed 10 Aug 2016

  • World Health Organization (WHO) (2016) Clinical management of patients with viral haemorrhagic fever: a pocket guide for the front-line health worker. Geneva, Switzerland

    Google Scholar 

Download references

Disclaimer

The findings and conclusions in this chapter are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Armand Sprecher .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Sprecher, A., Van Herp, M., Rollin, P.E. (2017). Clinical Management of Ebola Virus Disease Patients in Low-Resource Settings. In: Mühlberger, E., Hensley, L., Towner, J. (eds) Marburg- and Ebolaviruses. Current Topics in Microbiology and Immunology, vol 411. Springer, Cham. https://doi.org/10.1007/82_2017_18

Download citation

Publish with us

Policies and ethics